PDB Short entry for 2PJL HEADER TRANSCRIPTION 16-APR-07 2PJL TITLE CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR ALPHA IN COMPLEX TITLE 2 WITH A SYNTHETIC INVERSE AGONIST REVEALS ITS NOVEL MOLECULAR TITLE 3 MECHANISM COMPND MOL_ID: 1; COMPND 2 MOLECULE: STEROID HORMONE RECEPTOR ERR1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: ESTROGEN-RELATED RECEPTOR, ALPHA, ERR- ALPHA, ESTROGEN COMPND 6 RECEPTOR-LIKE 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESRRA, ERR1, ESRL1, NR3B1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN, LIGAND BINDING KEYWDS 2 POCKET, THREE-LAYERED ALPHA-HELICAL SANDWICH, INVERSE AGONIST, HELIX KEYWDS 3 12 (H12), COACTIVATOR GROOVE, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.KALLEN REVDAT 7 30-AUG-23 2PJL 1 REMARK REVDAT 6 20-OCT-21 2PJL 1 REMARK SEQADV REVDAT 5 18-OCT-17 2PJL 1 REMARK REVDAT 4 13-JUL-11 2PJL 1 VERSN REVDAT 3 24-FEB-09 2PJL 1 VERSN REVDAT 2 25-DEC-07 2PJL 1 JRNL REVDAT 1 12-JUN-07 2PJL 0 JRNL AUTH J.KALLEN,R.LATTMANN,R.BEERLI,A.BLECHSCHMIDT,M.J.BLOMMERS, JRNL AUTH 2 M.GEISER,J.OTTL,J.M.SCHLAEPPI,A.STRAUSS,B.FOURNIER JRNL TITL CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR ALPHA JRNL TITL 2 IN COMPLEX WITH A SYNTHETIC INVERSE AGONIST REVEALS ITS JRNL TITL 3 NOVEL MOLECULAR MECHANISM. JRNL REF J.BIOL.CHEM. V. 282 23231 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17556356 JRNL DOI 10.1074/JBC.M703337200 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 20528 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1056 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1416 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.53 REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE SET COUNT : 81 REMARK 3 BIN FREE R VALUE : 0.3630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3388 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 236 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.86000 REMARK 3 B22 (A**2) : 0.86000 REMARK 3 B33 (A**2) : -1.29000 REMARK 3 B12 (A**2) : 0.43000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.451 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.287 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.205 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.255 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3490 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4722 ; 1.127 ; 2.021 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 430 ; 4.433 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 144 ;35.015 ;24.028 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 628 ;16.513 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;20.057 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 564 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2528 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1677 ; 0.195 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2409 ; 0.292 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 217 ; 0.175 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 56 ; 0.177 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.250 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2256 ; 0.489 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3446 ; 0.848 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1423 ; 1.062 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1276 ; 1.685 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2PJL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-APR-07. REMARK 100 THE DEPOSITION ID IS D_1000042448. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8000 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20542 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 12.50 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : 0.06800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 10.40 REMARK 200 R MERGE FOR SHELL (I) : 0.24200 REMARK 200 R SYM FOR SHELL (I) : 0.24200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1XB7 WITH H12 REMOVED REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M MGCL2, 12%PEG400, 0.1M HEPES, REMARK 280 PH7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 48.23250 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.84705 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 44.86333 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 48.23250 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 27.84705 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 44.86333 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 48.23250 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 27.84705 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 44.86333 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.69409 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 89.72667 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 55.69409 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 89.72667 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 55.69409 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 89.72667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A DIMER AS IN THE ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 21560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48960 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -116.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 273 REMARK 465 SER A 274 REMARK 465 SER A 275 REMARK 465 HIS A 276 REMARK 465 HIS A 277 REMARK 465 HIS A 278 REMARK 465 HIS A 279 REMARK 465 HIS A 280 REMARK 465 HIS A 281 REMARK 465 PRO A 309 REMARK 465 ASP A 310 REMARK 465 PRO A 311 REMARK 465 ALA A 312 REMARK 465 GLY A 313 REMARK 465 PRO A 314 REMARK 465 ASP A 315 REMARK 465 GLY A 316 REMARK 465 HIS A 317 REMARK 465 ARG A 462 REMARK 465 ALA A 463 REMARK 465 GLY A 464 REMARK 465 PRO A 465 REMARK 465 GLY A 466 REMARK 465 GLY A 467 REMARK 465 GLY A 468 REMARK 465 ALA A 469 REMARK 465 GLU A 470 REMARK 465 MET A 518 REMARK 465 ASP A 519 REMARK 465 GLY B 273 REMARK 465 SER B 274 REMARK 465 SER B 275 REMARK 465 HIS B 276 REMARK 465 HIS B 277 REMARK 465 HIS B 278 REMARK 465 HIS B 279 REMARK 465 HIS B 280 REMARK 465 HIS B 281 REMARK 465 PRO B 309 REMARK 465 ASP B 310 REMARK 465 PRO B 311 REMARK 465 ALA B 312 REMARK 465 GLY B 313 REMARK 465 PRO B 314 REMARK 465 ASP B 315 REMARK 465 GLY B 316 REMARK 465 HIS B 317 REMARK 465 ARG B 462 REMARK 465 ALA B 463 REMARK 465 GLY B 464 REMARK 465 PRO B 465 REMARK 465 GLY B 466 REMARK 465 GLY B 467 REMARK 465 GLY B 468 REMARK 465 ALA B 469 REMARK 465 GLU B 470 REMARK 465 MET B 518 REMARK 465 ASP B 519 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO B 375 21.84 -78.12 REMARK 500 ALA B 414 6.43 -69.01 REMARK 500 ALA B 460 -71.02 -72.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 047 A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 047 B 700 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XB7 RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF APO ERRALPHA LBD IN COMPLEX WITH A PGC-1ALPHA REMARK 900 PEPTIDE AT 2.5A RESOLUTION DBREF 2PJL A 289 519 UNP P11474 ERR1_HUMAN 289 519 DBREF 2PJL B 289 519 UNP P11474 ERR1_HUMAN 289 519 SEQADV 2PJL GLY A 273 UNP P11474 CLONING ARTIFACT SEQADV 2PJL SER A 274 UNP P11474 CLONING ARTIFACT SEQADV 2PJL SER A 275 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS A 276 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS A 277 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS A 278 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS A 279 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS A 280 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS A 281 UNP P11474 CLONING ARTIFACT SEQADV 2PJL LEU A 282 UNP P11474 CLONING ARTIFACT SEQADV 2PJL GLU A 283 UNP P11474 CLONING ARTIFACT SEQADV 2PJL VAL A 284 UNP P11474 CLONING ARTIFACT SEQADV 2PJL LEU A 285 UNP P11474 CLONING ARTIFACT SEQADV 2PJL PHE A 286 UNP P11474 CLONING ARTIFACT SEQADV 2PJL GLN A 287 UNP P11474 CLONING ARTIFACT SEQADV 2PJL GLY A 288 UNP P11474 CLONING ARTIFACT SEQADV 2PJL SER A 325 UNP P11474 CYS 325 ENGINEERED MUTATION SEQADV 2PJL GLY B 273 UNP P11474 CLONING ARTIFACT SEQADV 2PJL SER B 274 UNP P11474 CLONING ARTIFACT SEQADV 2PJL SER B 275 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS B 276 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS B 277 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS B 278 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS B 279 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS B 280 UNP P11474 CLONING ARTIFACT SEQADV 2PJL HIS B 281 UNP P11474 CLONING ARTIFACT SEQADV 2PJL LEU B 282 UNP P11474 CLONING ARTIFACT SEQADV 2PJL GLU B 283 UNP P11474 CLONING ARTIFACT SEQADV 2PJL VAL B 284 UNP P11474 CLONING ARTIFACT SEQADV 2PJL LEU B 285 UNP P11474 CLONING ARTIFACT SEQADV 2PJL PHE B 286 UNP P11474 CLONING ARTIFACT SEQADV 2PJL GLN B 287 UNP P11474 CLONING ARTIFACT SEQADV 2PJL GLY B 288 UNP P11474 CLONING ARTIFACT SEQADV 2PJL SER B 325 UNP P11474 CYS 325 ENGINEERED MUTATION SEQRES 1 A 247 GLY SER SER HIS HIS HIS HIS HIS HIS LEU GLU VAL LEU SEQRES 2 A 247 PHE GLN GLY PRO VAL ASN ALA LEU VAL SER HIS LEU LEU SEQRES 3 A 247 VAL VAL GLU PRO GLU LYS LEU TYR ALA MET PRO ASP PRO SEQRES 4 A 247 ALA GLY PRO ASP GLY HIS LEU PRO ALA VAL ALA THR LEU SEQRES 5 A 247 SER ASP LEU PHE ASP ARG GLU ILE VAL VAL THR ILE SER SEQRES 6 A 247 TRP ALA LYS SER ILE PRO GLY PHE SER SER LEU SER LEU SEQRES 7 A 247 SER ASP GLN MET SER VAL LEU GLN SER VAL TRP MET GLU SEQRES 8 A 247 VAL LEU VAL LEU GLY VAL ALA GLN ARG SER LEU PRO LEU SEQRES 9 A 247 GLN ASP GLU LEU ALA PHE ALA GLU ASP LEU VAL LEU ASP SEQRES 10 A 247 GLU GLU GLY ALA ARG ALA ALA GLY LEU GLY GLU LEU GLY SEQRES 11 A 247 ALA ALA LEU LEU GLN LEU VAL ARG ARG LEU GLN ALA LEU SEQRES 12 A 247 ARG LEU GLU ARG GLU GLU TYR VAL LEU LEU LYS ALA LEU SEQRES 13 A 247 ALA LEU ALA ASN SER ASP SER VAL HIS ILE GLU ASP ALA SEQRES 14 A 247 GLU ALA VAL GLU GLN LEU ARG GLU ALA LEU HIS GLU ALA SEQRES 15 A 247 LEU LEU GLU TYR GLU ALA GLY ARG ALA GLY PRO GLY GLY SEQRES 16 A 247 GLY ALA GLU ARG ARG ARG ALA GLY ARG LEU LEU LEU THR SEQRES 17 A 247 LEU PRO LEU LEU ARG GLN THR ALA GLY LYS VAL LEU ALA SEQRES 18 A 247 HIS PHE TYR GLY VAL LYS LEU GLU GLY LYS VAL PRO MET SEQRES 19 A 247 HIS LYS LEU PHE LEU GLU MET LEU GLU ALA MET MET ASP SEQRES 1 B 247 GLY SER SER HIS HIS HIS HIS HIS HIS LEU GLU VAL LEU SEQRES 2 B 247 PHE GLN GLY PRO VAL ASN ALA LEU VAL SER HIS LEU LEU SEQRES 3 B 247 VAL VAL GLU PRO GLU LYS LEU TYR ALA MET PRO ASP PRO SEQRES 4 B 247 ALA GLY PRO ASP GLY HIS LEU PRO ALA VAL ALA THR LEU SEQRES 5 B 247 SER ASP LEU PHE ASP ARG GLU ILE VAL VAL THR ILE SER SEQRES 6 B 247 TRP ALA LYS SER ILE PRO GLY PHE SER SER LEU SER LEU SEQRES 7 B 247 SER ASP GLN MET SER VAL LEU GLN SER VAL TRP MET GLU SEQRES 8 B 247 VAL LEU VAL LEU GLY VAL ALA GLN ARG SER LEU PRO LEU SEQRES 9 B 247 GLN ASP GLU LEU ALA PHE ALA GLU ASP LEU VAL LEU ASP SEQRES 10 B 247 GLU GLU GLY ALA ARG ALA ALA GLY LEU GLY GLU LEU GLY SEQRES 11 B 247 ALA ALA LEU LEU GLN LEU VAL ARG ARG LEU GLN ALA LEU SEQRES 12 B 247 ARG LEU GLU ARG GLU GLU TYR VAL LEU LEU LYS ALA LEU SEQRES 13 B 247 ALA LEU ALA ASN SER ASP SER VAL HIS ILE GLU ASP ALA SEQRES 14 B 247 GLU ALA VAL GLU GLN LEU ARG GLU ALA LEU HIS GLU ALA SEQRES 15 B 247 LEU LEU GLU TYR GLU ALA GLY ARG ALA GLY PRO GLY GLY SEQRES 16 B 247 GLY ALA GLU ARG ARG ARG ALA GLY ARG LEU LEU LEU THR SEQRES 17 B 247 LEU PRO LEU LEU ARG GLN THR ALA GLY LYS VAL LEU ALA SEQRES 18 B 247 HIS PHE TYR GLY VAL LYS LEU GLU GLY LYS VAL PRO MET SEQRES 19 B 247 HIS LYS LEU PHE LEU GLU MET LEU GLU ALA MET MET ASP HET 047 A 600 25 HET 047 B 700 25 HETNAM 047 1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3- HETNAM 2 047 YL]METHYL}METHANAMINE FORMUL 3 047 2(C23 H28 N2) FORMUL 5 HOH *236(H2 O) HELIX 1 1 GLU A 283 GLY A 288 1 6 HELIX 2 2 PRO A 289 VAL A 300 1 12 HELIX 3 3 ALA A 320 LYS A 340 1 21 HELIX 4 4 GLY A 344 LEU A 348 5 5 HELIX 5 5 SER A 349 ARG A 372 1 24 HELIX 6 6 GLU A 390 ALA A 396 1 7 HELIX 7 7 GLU A 400 ALA A 414 1 15 HELIX 8 8 GLU A 418 ASN A 432 1 15 HELIX 9 9 ASP A 440 GLY A 461 1 22 HELIX 10 10 ARG A 471 LEU A 479 1 9 HELIX 11 11 THR A 480 LYS A 499 1 20 HELIX 12 12 LEU A 500 LYS A 503 5 4 HELIX 13 13 VAL A 504 ALA A 516 1 13 HELIX 14 14 GLU B 283 GLY B 288 1 6 HELIX 15 15 PRO B 289 VAL B 300 1 12 HELIX 16 16 ALA B 320 LYS B 340 1 21 HELIX 17 17 GLY B 344 LEU B 348 5 5 HELIX 18 18 SER B 349 ARG B 372 1 24 HELIX 19 19 ASP B 389 ALA B 396 1 8 HELIX 20 20 GLU B 400 ALA B 414 1 15 HELIX 21 21 GLU B 418 ASN B 432 1 15 HELIX 22 22 ASP B 440 GLY B 461 1 22 HELIX 23 23 ARG B 471 LEU B 479 1 9 HELIX 24 24 THR B 480 LYS B 499 1 20 HELIX 25 25 LEU B 500 LYS B 503 5 4 HELIX 26 26 VAL B 504 MET B 517 1 14 SHEET 1 A 2 GLU A 379 ALA A 383 0 SHEET 2 A 2 LEU A 386 ASP A 389 -1 O LEU A 388 N LEU A 380 SHEET 1 B 2 LEU B 380 ALA B 383 0 SHEET 2 B 2 LEU B 386 LEU B 388 -1 O LEU B 388 N LEU B 380 SITE 1 AC1 7 HOH A 5 VAL A 321 LEU A 324 GLU A 331 SITE 2 AC1 7 PHE A 382 GLY A 397 PHE A 495 SITE 1 AC2 10 HOH B 11 LEU B 324 PHE B 328 GLU B 331 SITE 2 AC2 10 PHE B 382 LEU B 386 GLY B 397 LEU B 398 SITE 3 AC2 10 PHE B 495 LEU B 500 CRYST1 96.465 96.465 134.590 90.00 90.00 120.00 H 3 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010366 0.005985 0.000000 0.00000 SCALE2 0.000000 0.011970 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007430 0.00000